Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:48:50 EDT Thu 09 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:APLIF
- APPILI THERAPEUTICS INC -
Website unknown - click to update
03:48:50 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
APLIF
- Q
not subscribed
0.0256
-0.00165
-6.1
30.0
1
3
0.0256
0.0256
0.0256
0.0755 0.0162
May 08
Apr 26
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market:
OTC Markets
-- Tier:
OTC Pink Current
-- Status:
Active
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Portfolio
Recent Trades - All 3 today
More trades...
Time ET
Ex
Price
Change
Volume
15:29:55
Q
0.0256
-0.00165
10,000
15:29:37
Q
0.0256
-0.00165
10,000
15:29:04
Q
0.0256
-0.00165
10,000
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-26 19:03
U:APLIF
News Release
200
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
2024-04-02 08:30
U:APLIF
News Release
200
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
2024-04-02 07:30
U:APLIF
News Release
200
Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
2024-03-12 07:12
U:APLIF
News Release
200
Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks
2023-12-15 07:27
U:APLIF
News Release
200
Appili Therapeutics Announces Issuance of Patent for ATI-1701 Biodefense Vaccine Candidate to Protect Against Tularemia and Provides Update on Bridge Loan
2023-11-13 16:24
U:APLIF
News Release
200
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2024
2023-10-25 07:49
U:APLIF
News Release
200
Appili Therapeutics ¢ € ™ Biodefense Vaccine Candidate ATI-1701 is Awarded Additional Funding from the U.S. Air Force Academy
2023-09-27 19:21
U:APLIF
News Release
200
Appili Therapeutics Announces Results of Annual Meeting of Shareholders and Provides Corporate Update
2023-09-27 07:27
U:APLIF
News Release
200
Appili Therapeutics Presents at the 10th International Tularemia Conference
2023-09-25 07:54
U:APLIF
News Release
200
Appili Therapeutics Announces U.S. FDA Approval of LIKMEZ ¢ „ ¢ (ATI-1501) Metronidazole Oral Suspension
2023-08-11 16:50
U:APLIF
News Release
200
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2024
2023-06-29 07:26
U:APLIF
News Release
200
Appili Therapeutics Announces Bridge Loan from Bloom Burton & Co.
2023-06-23 17:07
U:APLIF
News Release
200
Appili Therapeutics ¢ € “ Press Release Correction
2023-06-23 07:21
U:APLIF
News Release
200
Appili Therapeutics Reports Fiscal Year 2023 Financial and Operational Results
2023-05-24 07:19
U:APLIF
News Release
200
Appili Therapeutics Announces Issuance of Patent for ATI-1501 Liquid Oral Reformulation of Metronidazole